Pfizer Q3 profit beats estimates; oncology drugs shine

Tue Oct 29, 2013 7:10am EDT

Oct 29 (Reuters) - Pfizer Inc reported better-than-expected third-quarter earnings on Tuesday, helped by costs cuts and growing sales of recently approved cancer medicines.

The largest U.S. drugmaker said it earned $2.59 billion, or 39 cents per share, in the quarter, compared with $3.21 billion, or 43 cents per share, in the year-earlier period.

Excluding special items, Pfizer earned 58 cents per share. Analysts, on average, expected 56 cents per share, according to Thomson Reuters I/B/E/S.

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article